Another important announcement from last evening's call was that Unilife recently banked a $5 million payment that was NOT included in this quarter's financials.
Another reason why it is no wonder Shortall has invested millions of his own money in his undervalued stock.
faroutside you're wrong, the $5m was reported in the financials if you could read a balance sheet. papoua was right, the asset was $5m in AR and the liability was deferred revenue $5m (long term). So they'll start to amortize this $5m over a certain period. Just like the $3.187 milliion in revenue he claimed to do, well $2.3m of that was the amortized as part of the original Sanofi deal that ended when the new deal was announced.
The $5M is showing in receivables as an asset and in deferred revenue as a liability. It is a liability because they cannot claim the revenue until they provide the service. ie. they will be spending money to earn the $5M which explains why their R&D has gone up $1.7M. BTW, another fib from the conference call.... they never went below $18M in cash, they were at %5.7M last quarter.
I was just reading this. That meant that revenue could have been $8M for the quarter. I guess with this $5 million not yet accounted for, we can be assured that increase in sequential revenues will happen each quarter.